HIV / AIDS in the News

New AI tools aim to speed discovery of effective HIV vaccines - Digital Watch Observatory

 

Florida syphilis cases hit record high for new infections in this Treasure Coast county - Treasure Coast News

 

Readability and information quality of LLM-Generated HIV content: a methodological content evaluation - BMC Infectious Diseases

 

Could Crispr cure HIV? - Chemistry World

 

‘Alarming’ rise in HIV diagnosis rates needs attention, gov says - FemTech World

 

US excludes SA from ‘revolutionary’ HIV prevention meds, will only provide 300 000 doses globally - Polity.org.za

 

Progressive Multifocal Leukoencephalopathy Mimicking Stroke in a Patient With Newly Diagnosed HIV: A Case Report - Cureus

 

Progressive Multifocal Leukoencephalopathy Mimicking Stroke in a Patient With Newly Diagnosed HIV: A Case Report - Cureus

 

Fred Hutch researchers receive prestigious R01 research grants - Fred Hutchinson Cancer Center

 

Number of new HIV infections in Netherlands hasn't declined in five years - NL Times

 

Sister Mary Rose Bernard Groth, 1931-2025: Sister helped fight HIV/AIDS in Papua New Guinea - Toledo Blade

 

Educating The Masses About AIDS/HIV With One Global Event - Los Angeles Sentinel

 

Warning signs of HIV AIDS and 5 doctor-backed tips that can change everything - Times of India

 

Viral infections such as COVID, HIV, can raise heart disease risk, but vaccines may help - Managed Healthcare Executive

 

MSU expert discusses the importance of global HIV efforts - Michigan State University

 

World AIDS Day service to honor theme of ‘Living in a World with HIV’ - Coastal Point

 

Merck’s 2-Drug HIV Regimen Shows Noninferiority to Standard 3-Drug Therapy - Contagion Live

 

Maryland brothers convicted in South Florida black-market HIV drug scheme, feds say - WSVN

 

Merck & Co.'s HIV tablet matches Biktarvy in treatment-naïve patients - FirstWord Pharma

 

Merck’s Two-Drug HIV Regimen Matches Gilead’s Three-Drug Tablet - Merck & Co (NYSE:MRK) - Benzinga

 

Merck Says Its Two-Drug Regimen For HIV Treatment Proven Non-Inferior To Gilead’s Biktarvy In Study - Stocktwits

 

Medicaid: A Lifeline for People Living with HIV - POZ - Health, Life and HIV

 

NMAC Hires Chief Medical Officer To Bridge Public Health Disparities Through Community, Provider, And Policy Education - POZ - Health, Life and HIV

 

Merck's oral HIV treatment non-inferior to Gilead's Biktarvy in late-stage trial - Reuters

 

Merck’s oral HIV treatment meets main goal in late-stage study - The Mighty 790 KFGO

 

As HIV surges, Emory must lead its prevention - The Emory Wheel

 

LGBTQ Agenda: HIV Advocates Blast Delta Air Lines Over PrEP Coverage Hurdles - Lavender Magazine

 

SCOPE: EATG Launches Opportunities to Amplify Community Voices in HIV Prevention - European AIDS Treatment Group

 

Launch of WHO Integrated drug resistance action framework for HIV, hepatitis B and C, and STIs - World Health Organization (WHO)

 

HIV fight at risk as Macron expected to skip major health summit - Euractiv